Featured Research

from universities, journals, and other organizations

Specific genetic cue for sudden cardiac death syndrome found

Date:
February 18, 2014
Source:
University of California - Irvine
Summary:
Researchers have found a specific genetic flaw that is connected to sudden death due to heart arrhythmia -- a leading cause of mortality for adults around the world. While a number of genes have been linked with arrhythmias, new researcher has uncovered that the functional impairment of a gene called KCNE2 underlies a multisystem syndrome that affects both heart rhythm and blood flow and can activate chemical triggers that can cause sudden cardiac death.

UC Irvine researchers have found a specific genetic flaw that is connected to sudden death due to heart arrhythmia -- a leading cause of mortality for adults around the world.

Related Articles


While a number of genes have been linked with arrhythmias, UC Irvine's Geoffrey Abbott and his colleagues discovered that the functional impairment of a gene called KCNE2 underlies a multisystem syndrome that affects both heart rhythm and blood flow and can activate chemical triggers that can cause sudden cardiac death.

"With these findings, we can now explore improved early detection and prevention strategies for people who are at higher risk of sudden cardiac death, such as those with diabetes," said Abbott, a professor of pharmacology and physiology & biophysics in the UC Irvine School of Medicine.

Study results appear in the February issue of Circulation: Cardiovascular Genetics, a publication of the American Heart Association.

Distinct from a heart attack, in which the heart continues to beat but blood flow is blocked, sudden cardiac death occurs when the heart ceases to beat because of the uncontrolled twitching of muscle fibers in its ventricles. Without defibrillation within minutes, this type of event is fatal.

In studies on a mouse model with the KCNE2 gene removed, Abbott and his colleagues had found catalysts for sudden cardiac death -- including high blood cholesterol, anemia, high blood potassium, an age-related delay in the return to a resting position of the ventricle after contraction and, most surprisingly, diabetes.

Abbott said this link to diabetes and other systemic disturbances is significant because genes such as KCNE2 are better known for directly controlling the electrical signaling that ensures a steady heartbeat. The KCNE2 gene provides instructions for making a protein that regulates the activity of potassium channels, which play a key role in a cell's ability to generate and transmit electrical signals. Channels regulated by the KCNE2 protein are present in heart muscles and help recharge them after each heartbeat to maintain a regular rhythm.

In the current study, the researchers expanded on their previous work by showing that KCNE2 disruptions affect these rhythms in cardiac cells, which increases the risk of arrhythmia. Abbott said the major breakthrough in this study is that KCNE2 deletion could adversely affect so many other tissues outside the heart and that this dramatically worsened the outcome of cardiac electrical disturbances.

"Our discovery that a single gene disruption can give rise to a multitissue syndrome that predisposes one to sudden cardiac death challenges the established thinking that this type of genetic disruption can only give rise to a single component, such as abnormal electrical signaling in cardiac cells," Abbott said.

He pointed out that the use of full-gene knockout mice presents an exaggerated form of what occurs in human genetic syndromes.

"It's important to note that the mouse heart is very resistant to developing ventricular fibrillation," he said. "So the fact that we kept seeing this arrhythmia in the KCNE2-deleted mice gives us confidence that these findings are significant. We're currently using the same mouse model to investigate the mechanisms of myocardial infarction, another major cause of mortality recently associated with the KCNE2 gene."

The gene's relationship to diabetes is another area Abbott's group is exploring. He said that one of the potassium channels regulated by KCNE2 is strongly linked to human diabetes and is present in the islet cells of the pancreas, so one goal is to screen people with diabetes for DNA sequence variances in KCNE2.


Story Source:

The above story is based on materials provided by University of California - Irvine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Z. Hu, R. Kant, M. Anand, E. C. King, T. Krogh-Madsen, D. J. Christini, G. W. Abbott. Kcne2 Deletion Creates a Multisystem Syndrome Predisposing to Sudden Cardiac Death. Circulation: Cardiovascular Genetics, 2014; 7 (1): 33 DOI: 10.1161/CIRCGENETICS.113.000315

Cite This Page:

University of California - Irvine. "Specific genetic cue for sudden cardiac death syndrome found." ScienceDaily. ScienceDaily, 18 February 2014. <www.sciencedaily.com/releases/2014/02/140218143326.htm>.
University of California - Irvine. (2014, February 18). Specific genetic cue for sudden cardiac death syndrome found. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2014/02/140218143326.htm
University of California - Irvine. "Specific genetic cue for sudden cardiac death syndrome found." ScienceDaily. www.sciencedaily.com/releases/2014/02/140218143326.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins